Updated: Jun 23, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
1Kent Oncology Centre, Kent, UK.
This systematic review examines first-line treatments for aggressive non-Hodgkin's lymphoma (NHL). It evaluates the effectiveness and safety of various chemotherapy regimens and stem cell support options for NHL patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: